Under these experimental conditions, the release of IL-1β is exacerbated by LPS in samples from CAPS patients compared to those carrying wild type NLRP3, while it is usually undetectable in unprimed cells. The gene discussed is IL1B; the disease is cryopyrin-associated periodic syndrome.